deaths from glp 1 Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study Mapping the effectiveness and risks

It is used in a concentration of 1-5% for a limited duration

PMID: 24520096

In the phase 3 ACHIEVE-3 trial , adults with type 2 diabetes inadequately controlled by metformin were randomized to receive orforglipron or oral semaglutide (7 mg and 14 mg, doses approved for type 2 diabetes)

Cario H, Smith DEC, Blom H, Blau N, Bode H, Holzmann K, et al

The full 7-day plan already does that, with soups, bowls, soft egg meals, and protein anchors mapped across the week so the calories and protein land without you tracking every bite

As you lose weight, your resting metabolic ratethe calories you burn at restnaturally decreases to conserve energy